NCT00540423 - Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Chronic Idiopathic Thrombocytopenic PurpuraPurpura, Thrombocytopenic, Idiopathic

Interventions

DRUG

SB-497115-GR 12.5mg

SB-497115-GR 12.5mg tablet once a day

DRUG

SB-497115-GR 25mg

SB-497115-GR 25mg tablet once a day

DRUG

SB-497115-GR 12.5mg matching placebo

SB-497115-GR 12.5mg matching placebo x1 or 2 tablet once a day

DRUG

SB-497115-GR 50 mg

SB-497115-GR 25mg tablet x2 once a day

Trial Locations (7)

GSK Investigational Site, Gifu

GSK Investigational Site, Hiroshima

GSK Investigational Site, Ibaraki

GSK Investigational Site, Osaka

GSK Investigational Site, Osaka

GSK Investigational Site, Tochigi

GSK Investigational Site, Tokyo